Additionally, cannabis-related cognitive impairment might reduce awareness of hypoglycaemic symptoms (low blood sugar), such as tremor, sweating, or confusion, potentially delaying appropriate treatment
Carol Fabian, who has been investigating the effects of the GLP-1 receptor agonist tirzepatide on blood, imaging, and breast tissue biomarkers in women with obesity and other risk factors for breast cancer
Sobos tirzepatide page explains that tirzepatide is a dual GIP and GLP-1 receptor agonist and is the ingredient in Mounjaro and Zepbound
doi: 10.1007/s10517-007-0159-y
Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA): NRG-GI008
Wegovy is registered specifically for weight management in people with obesity or weight-related medical conditions